CLINICAL_TRIALS
trial_result
· 2017-05-10
Clinical Trial Update: Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder [Phase 2]
Summary
Phase 2 trial evaluating memantine augmentation in treatment-resistant adults with obsessive-compulsive disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-05-10